Last checked at 8 Mar 2016 07:00
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Appointment of Christopher Buckley to the Board of Directors
8 March 2016
Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, is pleased to announce the appointment of Mr Christopher Buckley to its Board of Directors.
Mr Buckley has more than 30 years of international marketing and general management experience in the global Pharmaceutical industry with a proven track record of translating scientific innovations into competitive customer-focused benefits. Most recently, he was a Global Brand Director at Novartis, at which he spent the majority of his career progressing through a variety of local, regional and global roles. He brings Microsaic a wealth of strategic management experience, coupled with the pragmatic and commercial expertise to effectively grow global brands. Mr Buckley holds a B.Sc. Hons in Pharmacology and Physiology from the University of Aston, UK.
Colin Nicholl, Microsaic Chairman, said: "Microsaic has made an encouraging start to 2016 executing its new strategy and building on progress in the second half of last year. We are therefore delighted to welcome Chris Buckley to the Board. We look forward to his contribution to the delivery of important commercial milestones that aim to capture further value from the Company's suite of miniaturised analytical instruments and innovative technologies."
No further information is required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules for Companies in respect of the appointment of Christopher Buckley (aged 54) to the board.
Contacts
Microsaic Systems Colin Nicholl, Chairman Jim Ramage, CEO
| Via Citigate Dewe Rogerson |
Numis Securities Limited Stuart Skinner (Nominated Adviser) Tom Ballard (Broker)
| +44 (0)20 7260 1000 |
Citigate Dewe Rogerson Mark Swallow, Marine Perrier | +44 (0)20 7282 2948/1068
|
About Microsaic Systems
Microsaic Systems plc is a high technology company developing and marketing next generation mass spectrometry (MS) instruments for the analysis of gaseous, liquid and solid samples. Microsaic has successfully miniaturised mass spectrometry into a desktop instrument by integrating the key MS components onto patented chip technologies (called ionchip®, spraychip® and vac-chip™). Microsaic's MS products retain the functionality of larger, conventional MS systems but are substantially smaller, lighter, consume less energy and have lower running costs. The Microsaic 4000 MiD® is the world's smallest MS system.
Mass spectrometry is a 'gold-standard' analytical technique used across many industry sectors, including pharmaceutical, diagnostics and healthcare, government, energy, utilities, environmental, food and drink, security and defence, and industrial chemicals - a combined market estimated to grow to $2.5 billion by 2017. Microsaic aims to introduce compact, deployable MS products, based on its core technology, into a series of these target markets.
Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.
www.microsaic.com